156 related articles for article (PubMed ID: 16374232)
1. Clinicopathological features of melanocytic skin lesions in Egypt.
Hussein MR; Elsers DA; Fadel SA; Omar AE
Eur J Cancer Prev; 2006 Feb; 15(1):64-8. PubMed ID: 16374232
[TBL] [Abstract][Full Text] [Related]
2. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
3. Melanocytic naevi, melanoma and sun exposure.
Augustsson A
Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
[TBL] [Abstract][Full Text] [Related]
4. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
5. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
[TBL] [Abstract][Full Text] [Related]
6. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
7. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas.
Hussein MR; Roggero E; Sudilovsky EC; Tuthill RJ; Wood GS; Sudilovsky O
Am J Dermatopathol; 2001 Aug; 23(4):308-14. PubMed ID: 11481522
[TBL] [Abstract][Full Text] [Related]
8. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study.
Stierner U; Augustsson A; Rosdahl I; Suurküla M
Melanoma Res; 1992; 1(5-6):367-75. PubMed ID: 1422192
[TBL] [Abstract][Full Text] [Related]
10. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
11. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
12. Association of clinicopathological features of melanoma with total naevus count and a history of dysplastic naevi: a cross-sectional retrospective study within an academic centre.
Tan SY; Strazzulla LC; Li X; Park JJ; Lee SJ; Kim CC
Clin Exp Dermatol; 2018 Jul; 43(5):566-572. PubMed ID: 29450912
[TBL] [Abstract][Full Text] [Related]
13. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
14. The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions.
Blum A; Soyer HP; Garbe C; Kerl H; Rassner G; Hofmann-Wellenhof R
Br J Dermatol; 2003 Dec; 149(6):1159-64. PubMed ID: 14674892
[TBL] [Abstract][Full Text] [Related]
15. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
Cockerell CJ; Berson DS
Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
18. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
19. [Nevus and malignant cutaneous melanoma].
Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry.
Breitbart M; Garbe C; Büttner P; Weiss J; Soyer HP; Stocker U; Krüger S; Breitbart EW; Weckbecker J; Panizzon R; Bahmer F; Tilgen W; Guggenmoos-Holzmann I; Orfanos CE
Acta Derm Venereol; 1997 Sep; 77(5):374-8. PubMed ID: 9298131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
